
Celgene to buy Seattle biotech Juno for $9 billion to get promising cancer treatments
Celgene agreed to buy Juno Therapeutics of Seattle for about $9 billion, one of its largest deals ever, in a bid to expand in the...
Celgene agreed to buy Juno Therapeutics of Seattle for about $9 billion, one of its largest deals ever, in a bid to expand in the...
South San Francisco biotech company received $1.5 million to help finance testing of an experimental drug to improve lung function in ALS patients.